CAMBRIDGE, Mass., Feb. 6, 2007 (PRIME NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, today announced that executive management will present a company overview and participate in a panel discussion at the BIO CEO & Investor Conference at the Waldorf-Astoria Hotel in New York City.
Julian Adams, Ph.D., President and Chief Scientific Officer, will be participating in a panel discussion titled "Attacking Cancer's Achilles Heel -- Hot Targets in the Pipeline for Oncology Treatment" on Monday, February 12, 2007, at 9:30 a.m. EST.
Steven H. Holtzman, Chief Executive Officer, will be presenting a company overview on Tuesday, February 13, 2007, at 2:15 p.m. EST. A live webcast of Infinity's presentation will be accessible on the company's website at http://www.ipi.com and will be archived on the website for 30 days.
About Infinity Pharmaceuticals, Inc.
Infinity is an innovative cancer drug discovery and development company that is seeking to leverage its strength in small molecule drug technologies to discover, develop, and deliver to patients first-in-class or best-in-class medicines for the treatment of cancer and related conditions. For more information on Infinity, please refer to the company's website at http://www.ipi.com.